Intervention Review

Oral vasodilators for primary Raynaud's phenomenon

  1. Bergljot Vinjar1,*,
  2. Marlene Stewart2

Editorial Group: Cochrane Peripheral Vascular Diseases Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 17 DEC 2007

DOI: 10.1002/14651858.CD006687.pub2

Database Title

Additional Information

How to Cite

Vinjar B, Stewart M. Oral vasodilators for primary Raynaud's phenomenon. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD006687. DOI: 10.1002/14651858.CD006687.pub2.

Author Information

  1. 1

    Møre and Romsdal County, Department of Health and Social Services, Molde, Norway

  2. 2

    University of Edinburgh, Public Health Sciences, Edinburgh, UK

*Bergljot Vinjar, Department of Health and Social Services, Møre and Romsdal County, Fylkeshusa, Molde, 6407, Norway. bergljot.vinjar@nesset.post.no. bergljot.vinjar@fmmr.no.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 JUL 2008

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (385K)Full (464K)

  1. Current Version

    Oral vasodilators for primary Raynaud's phenomenon

    Bergljot Vinjar and Marlene Stewart

    Article first published online: 16 JUL 2008 | DOI: 10.1002/14651858.CD006687.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Oral vasodilators for primary Raynaud's Phenomenon

    B Vinjar

    Article first published online: 23 JAN 2008 | DOI: 10.1002/14651858.CD006687

View Full Article (HTML) Summary (59K)Standard (385K)Full (464K)